HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer

Pancreatic cancer is one of the most aggressive solid malignancies prone to metastasis. Epithelial-mesenchymal transition (EMT) contributes to cancer invasiveness and drug resistance. In this study, we investigated whether HS-173, a novel PI3K inhibitor blocked the process of EMT in pancreatic cance...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Rumman, Marufa, Jung, Kyung Hee, Fang, Zhenghuan, Yan, Hong Hua, Son, Mi Kwon, Kim, Soo Jung, Kim, Juyoung, Park, Jung Hee, Lim, Joo Han, Hong, Sungwoo, Hong, Soon-Sun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363641/
https://ncbi.nlm.nih.gov/pubmed/27793006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12871
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak